Key result
Ischemic postconditioning reduced infarct size from 41% to 28% in non-diabetic rats, but failed to provide significant cardioprotection in chronic diabetic rats.
Why the study?
Does ischemic postconditioning reduce myocardial infarct size and oxidative stress in chronic diabetic male rats?
Does ischemic postconditioning reduce myocardial infarct size and oxidative stress in chronic diabetic male rats?
Chronic diabetes abolishes the infarct-limiting cardioprotective effects of ischemic postconditioning, a failure associated with impaired phosphorylation of GSK-3β and unmitigated oxidative stress.
Answers are grounded in this paper and cite their sources.
Diabetes may abolish postconditioning protection in rats; hypothesis-generating for loss of benefit in diabetic patients.
PURPOSE: Diabetes mellitus as a main risk-factor of ischemic heart disease may interfere with postconditioning'scardioprotective effects. This study aimed to investigate the involvement of glycogen synthase kinase-3β (GSK-3β) and oxidation status in chronic diabetes-induced loss of cardioprotective effect of ischemic-postconditioning (IPostC) in Wistar rats. METHODS: After 8 weeks of induction of diabetes by streptozotocin (50mg/kg), hearts of control and diabetic rats were isolated and mounted on a constant-pressure Langendorff system. All hearts were subjected to 30min regional ischemia followed by 60min reperfusion (by occluding and re-opening of left anterior descending coronary artery, respectively). IPostC was applied immediately at the onset of reperfusion. At the end of reperfusion, the infarct size of myocardium was measured via computerized planimetry. Myocardial contents of malondealdehyde and glutathione as indices of oxidative status were assayed spectrophotometrically and the total and phosphorylated forms of myocardial GSK-3β were quantified through western blotting. RESULTS: IPostC reduced the infarct size of control hearts from 41±2.9% to 28±1.9% (P<0.05), whereas it could not induce significant changes in infarct size of diabetic animals (35±1.8% vs. 39±3.1%). IPostC-induced reduction in malondealdehyde and elevation in glutathione contents were significant only in control not in diabetic hearts. The total forms of GSK-3β were similar in all groups; however, the phosphorylation of GSK-3β (at Ser9) by IPostC was greater in control hearts than diabetics (P<0.01). CONCLUSION: The failure of cardioprotection by IPostC in diabetic hearts may be attributed to the loss of phosphorylation of GSK-3β and thereby increase in oxidative stress in diabetic states.
No takes yet. Share an insight, caveat, or question.
Badalzadeh et al. (2015) studied Myocardial ischemia-reperfusion injury in chronic diabetes (n=42). Ischemic postconditioning (IPostC) vs. No ischemic postconditioning was evaluated on Infarct size (% of risk zone) (p=<0.05). Ischemic postconditioning reduced infarct size from 41% to 28% in non-diabetic rats, but failed to provide significant cardioprotection in chronic diabetic rats.
Synapse has enriched 10 related papers. Consider them for comparative context: